Breaking News Instant updates and real-time market news.

USNA

Usana

$82.96 /

-0.16 (-0.19%)

11:38
06/11/20
06/11
11:38
06/11/20
11:38

Usana issued patent for InCelligence Complex formula

Usana announced it has been issued a U.S. patent for its In Celligence Complex formula. The patent, US Pat. No. 10,632,101, recognizes the InCelligence Complex formula contains antioxidant compounds that support endogenous systems associated with optimal lifespans, the company said in a statement. The patent was submitted by USANA R&D scientists, Drs. Mark Brown, Jeremy Tian, and John Cuomo. "USANA has always been considered a pioneer in the health and wellness industry, and this patent separates us even further from the competition," says Dr. Rob Sinnott, USANA's chief scientific officer.

USNA Usana
$82.96 /

-0.16 (-0.19%)

10/30/19 Stifel
Nu Skin upgraded to Hold on 'less bad' China expectations at Stifel
08/22/19 Jefferies
Jefferies starts Usana at Hold, says waiting on China rebound
08/22/19 Jefferies
Usana initiated with a Hold at Jefferies
07/03/19 Sidoti
Usana downgraded to Neutral from Buy at Sidoti

TODAY'S FREE FLY STORIES

Periodicals
uniQure patent gets IPR review after challenge from Pfizer » 14:07
07/13/20
07/13
14:07
07/13/20
14:07
QURE

uniQure

$47.33 /

+0.91 (+1.96%)

, PFE

Pfizer

$35.56 /

+1.72 (+5.08%)

A trial was instituted at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Guggenheim
uniQure HemB deal 'not the M&A some investors were hoping for,' says Guggenheim
06/25/20 H.C. Wainwright
uniQure price target lowered to $64 from $73 at H.C. Wainwright
06/25/20 Stifel
uniQure price target lowered to $78 from $86 at Stifel
PFE Pfizer
$35.56 /

+1.72 (+5.08%)

09:45 Today Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

  • 06
    Sep
PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

Hot Stocks
easyJet pilots call for vote of no confidence in COO Peter Bellew » 14:06
07/13/20
07/13
14:06
07/13/20
14:06
ESYJY

easyJet

$0.00 /

+ (+0.00%)

Following easyJet's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESYJY easyJet
$0.00 /

+ (+0.00%)

12:20 Today JPMorgan
JPMorgan backs Neutral on easyJet
06/30/20 UBS
easyJet price target lowered to 1,240 GBp from 1,320 GBp at UBS
04/23/20 Morgan Stanley
easyJet downgraded to Equal Weight from Overweight at Morgan Stanley
04/17/20 Oddo BHF
easyJet upgraded to Buy from Neutral at Oddo BHF
Options
Penn National call volume above normal and directionally bullish » 14:05
07/13/20
07/13
14:05
07/13/20
14:05
PENN

Penn National

$30.97 /

+1.52 (+5.16%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

06/23/20 Stifel
Penn National price target raised to $39 from $23 at Stifel
06/09/20 Susquehanna
Penn National downgraded to Neutral from Positive at Susquehanna
06/09/20 Susquehanna
Penn National downgraded to Neutral from Positive at Susquehanna
06/08/20
Fly Intel: Top five analyst downgrades
PENN Penn National
$30.97 /

+1.52 (+5.16%)

  • 12
    May
PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

General news
Treasury Budget data reported » 14:03
07/13/20
07/13
14:03
07/13/20
14:03

June Treasury Budget at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Wall Street has continued to climb higher » 14:00
07/13/20
07/13
14:00
07/13/20
14:00

Wall Street has continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BioSig announces enrollment of adult patients for ViralClear Phase 2 COVID trial » 13:45
07/13/20
07/13
13:45
07/13/20
13:45
BSGM

BioSig Technologies

$7.36 /

+0.16 (+2.22%)

BioSig Technologies and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Roth Capital
BioSig Technologies initiated with a Buy at Roth Capital
  • 21
    Feb
BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

General news
Fed's Kaplan continues to argue for more fiscal support » 13:45
07/13/20
07/13
13:45
07/13/20
13:45

Fed's Kaplan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Treasury Budget to be reported at 14:00 » 13:45
07/13/20
07/13
13:45
07/13/20
13:45

June Treasury Budget will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
$80M call block in SPYder ETF tied to 2.88M shares » 13:40
07/13/20
07/13
13:40
07/13/20
13:40
SPY

SPDR S&P 500 ETF Trust

$322.27 /

+4.66 (+1.47%)

$80M call block in SPYder…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

Syndicate
Tonix Pharmaceuticals prices $10.5M common stock offering » 13:38
07/13/20
07/13
13:38
07/13/20
13:38
TNXP

Tonix Pharmaceuticals

$0.55 /

-0.0925 (-14.50%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

Downgrade
Morgan Stanley sees greater uncertainty on NC318, cuts NextCure to Equal Weight » 13:30
07/13/20
07/13
13:30
07/13/20
13:30
NXTC

NextCure

$9.82 /

-7.98 (-44.83%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

NXTC NextCure
$9.82 /

-7.98 (-44.83%)

13:17 Today Morgan Stanley
NextCure downgraded to Equal Weight from Overweight at Morgan Stanley
11:31 Today JMP Securities
NextCure downgraded to Market Perform from Outperform at JMP Securities
09:23 Today SunTrust
NextCure downgraded to Hold from Buy at SunTrust
09:19 Today Roth Capital
NextCure downgraded to Neutral at Roth Capital after Phase II trial update
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

  • 15
    Nov
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

Hot Stocks
Eldorado Resorts gets Indiana HRC approval for Caesars deal » 13:26
07/13/20
07/13
13:26
07/13/20
13:26
ERI

Eldorado Resorts

$41.09 /

+0.93 (+2.32%)

, CZR

Caesars

$12.30 /

+0.085 (+0.70%)

Eldorado Resorts (ERI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/12/20 SunTrust
SunTrust raises price target on select Gaming names amid positive room-rate data
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
CZR Caesars
$12.30 /

+0.085 (+0.70%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura Instinet
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

  • 17
    Jun
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

Hot Stocks
Kopin shares up 47c, or 36%, in afternoon trading » 13:25
07/13/20
07/13
13:25
07/13/20
13:25
KOPN

Kopin

$1.81 /

+0.505 (+38.70%)

At time of writing, Kopin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOPN Kopin
$1.81 /

+0.505 (+38.70%)

Options
Pinduoduo call volume above normal and directionally bullish » 13:25
07/13/20
07/13
13:25
07/13/20
13:25
PDD

Pinduoduo

$92.36 /

+5.06 (+5.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

06/24/20 Macquarie
Pinduoduo price target raised to $116 from $90 at Macquarie
06/19/20 Morgan Stanley
6.18 promotion in China released pent-up buying demand, says Morgan Stanley
06/16/20 Outperform, Neutral, Underperform
Pinduoduo initiated with an Outperform at ICBC
06/08/20
Fly Intel: Top five analyst initiations
PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

Conference/Events
Wolfe Research financial analyst to hold an analyst/industry webcast » 13:25
07/13/20
07/13
13:25
07/13/20
13:25

Analysts, along with an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
NextCure downgraded to Equal Weight from Overweight at Morgan Stanley » 13:17
07/13/20
07/13
13:17
07/13/20
13:17
NXTC

NextCure

$9.95 /

-7.855 (-44.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

NXTC NextCure
$9.95 /

-7.855 (-44.13%)

11:31 Today JMP Securities
NextCure downgraded to Market Perform from Outperform at JMP Securities
09:23 Today SunTrust
NextCure downgraded to Hold from Buy at SunTrust
09:19 Today Roth Capital
NextCure downgraded to Neutral at Roth Capital after Phase II trial update
09:05 Today Roth Capital
NextCure downgraded to Neutral from Buy at Roth Capital
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

  • 15
    Nov
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

Technical Analysis
NASDAQ market internals summary » 13:17
07/13/20
07/13
13:17
07/13/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 13:16
07/13/20
07/13
13:16
07/13/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Scotiabank backs Outperform on Tricon Capital » 13:15
07/13/20
07/13
13:15
07/13/20
13:15
TCNGF

Tricon Capital

$0.00 /

+ (+0.00%)

Scotiabank analyst Mario…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCNGF Tricon Capital
$0.00 /

+ (+0.00%)

06/12/20 Scotiabank
Tricon Capital price target raised to C$11 from C$10.25 at Scotiabank
05/26/20 TD Securities
Tricon Capital price target lowered to C$11.50 from C$12 at TD Securities
05/19/20 Stifel
Tricon Capital price target lowered to C$12 from C$14.25 at Stifel
05/19/20 CIBC
Tricon Capital price target lowered to C$12 from C$13.75 at CIBC
Periodicals
Eldorado, Caesars deal approved in Indiana, Casino News reports » 13:15
07/13/20
07/13
13:15
07/13/20
13:15
ERI

Eldorado Resorts

$40.62 /

+0.46 (+1.15%)

, CZR

Caesars

$12.25 /

+0.03 (+0.25%)

The Indiana Horse Racing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/12/20 SunTrust
SunTrust raises price target on select Gaming names amid positive room-rate data
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
CZR Caesars
$12.25 /

+0.03 (+0.25%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura Instinet
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

  • 17
    Jun
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

Recommendations
Level2 could be significant for Dexcom CGM utilization, says Piper Sandler » 13:15
07/13/20
07/13
13:15
07/13/20
13:15
DXCM

DexCom

$436.66 /

-2.27 (-0.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$436.66 /

-2.27 (-0.52%)

DXCM DexCom
$436.66 /

-2.27 (-0.52%)

07/07/20 Cowen
DexCom price target raised to $450 from $430 at Cowen
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/10/20 Piper Sandler
Tandem Diabetes the 'standout' in Piper endocrinologist survey
06/09/20 Cowen
DexCom price target raised to $430 from $360 at Cowen
DXCM DexCom
$436.66 /

-2.27 (-0.52%)

DXCM DexCom
$436.66 /

-2.27 (-0.52%)

DXCM DexCom
$436.66 /

-2.27 (-0.52%)

Recommendations
Scotiabank backs Sector Perform on MTY Food Group after 'solid' quarter » 13:14
07/13/20
07/13
13:14
07/13/20
13:14
MTYFF

MTY Food Group

$0.00 /

+ (+0.00%)

Scotiabank analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTYFF MTY Food Group
$0.00 /

+ (+0.00%)

13:04 Today RBC Capital
MTY Food Group price target raised to C$27 from C$22 at RBC Capital
12:59 Today National Bank
MTY Food Group price target raised to C$32 from C$29 at National Bank
10:35 Today National Bank
MTY Food Group price target raised to C$32 from C$29 at National Bank
10:33 Today TD Securities
MTY Food Group price target raised to C$28 from C$24 at TD Securities
Recommendations
Shaw Communications price target raised to C$31.50 from C$30.50 at Scotiabank » 13:13
07/13/20
07/13
13:13
07/13/20
13:13
SJR

Shaw Communications

$17.53 /

+0.98 (+5.92%)

Scotiabank analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJR Shaw Communications
$17.53 /

+0.98 (+5.92%)

SJR Shaw Communications
$17.53 /

+0.98 (+5.92%)

13:05 Today RBC Capital
Shaw Communications price target raised to C$25 from C$24 at RBC Capital
13:00 Today National Bank
National Bank backs Outperform on Shaw Communications after Q3 results
12:55 Today CIBC
CIBC backs Outperformer rating on Shaw Communications after 'solid' Q3
12:52 Today BMO Capital
BMO backs Market Perform on Shaw Communications after Q3 results
SJR Shaw Communications
$17.53 /

+0.98 (+5.92%)

SJR Shaw Communications
$17.53 /

+0.98 (+5.92%)

Hot Stocks
UnitedHealth launches new Level2 digital health therapy » 13:11
07/13/20
07/13
13:11
07/13/20
13:11
UNH

UnitedHealth

$300.68 /

+9.375 (+3.22%)

UnitedHealth Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

07/07/20 Cantor Fitzgerald
UnitedHealth likely to reiterate 2020 outlook, says Cantor Fitzgerald
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

UNH UnitedHealth
$300.68 /

+9.375 (+3.22%)

Recommendations
Shaw Communications price target raised to C$25 from C$24 at RBC Capital » 13:05
07/13/20
07/13
13:05
07/13/20
13:05
SJR

Shaw Communications

$17.50 /

+0.95 (+5.74%)

RBC Capital analyst Drew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJR Shaw Communications
$17.50 /

+0.95 (+5.74%)

SJR Shaw Communications
$17.50 /

+0.95 (+5.74%)

13:00 Today National Bank
National Bank backs Outperform on Shaw Communications after Q3 results
12:55 Today CIBC
CIBC backs Outperformer rating on Shaw Communications after 'solid' Q3
12:52 Today BMO Capital
BMO backs Market Perform on Shaw Communications after Q3 results
10:35 Today TD Securities
Shaw Communications price target raised to C$32 from C$31 at TD Securities
SJR Shaw Communications
$17.50 /

+0.95 (+5.74%)

SJR Shaw Communications
$17.50 /

+0.95 (+5.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.